The risk of dying from cancer is highest in the Northeast and the lowest in Bihar, Jharkhand and Orissa, according to a new study described as the first to provide direct nationally-representative estimates of cancer deaths across the country. The study by researchers at the Centre for Global Health Research at the University of Toronto, Canada, and Indian institutions has shown large variations in cancer risk across the states, but suggests...

The ongoing debate over the incidence of poverty in India, often assuming surreal proportions, shows that there is indeed a ‘philosophy of poverty’ guiding current economic reforms. The loot of our country’s resources that is taking place both through these reforms, which continue to widen gross inequalities, and through the open plunder of our resources for private gain — as reflected in the series of mega scams — require the legitimacy...

-IANS Debunking the government's claim that the number of poor  in India has come down, a top adviser has claimed that around 70 % of the country's 1.2 billion population is poor, and stressed the need for a multi-dimensional assessment of poverty.  "The government claim that poverty has come down is not valid... there is a need for a multi-dimensional assessment of poverty as around 70% of the population is poor," National Advisory...

One man’s fiscal problem is another man’s lifeline. Trigger happy bureaucrats and economists may love shooting down subsidies because it bloats the fiscal deficit and burdens the government but the simple fact is that in a one billion strong nation, in which nearly one in every three live below the poverty line, one needs an effective and efficient method through which privileged tax payers can support the poor. Last week, finance...

India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...